Last reviewed · How we verify
NCT06804408
Unpacking the "Mind" and "Body" Pathways of the Antidepressant Effect of Qigong in Older Adults: A Pilot Study
NA trial testing Qigong in Qigong in 106 participants. Completed in 31 August 2024.
31 May 2024
Quick facts
| Lead sponsor | The Hong Kong Polytechnic University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 106 |
| Start date | 1 May 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Qigong
- Mindfulness-based training
- Low-to-moderate intensity physical exercise
Conditions studied
- Qigong — all drugs for Qigong →
Sponsor
The Hong Kong Polytechnic University
Who can join
60 and older, any sex, with Qigong. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goals of the study are to explore the neurobiological mechanisms and cognitive benefits of qigong in older adults. The main research questions are: * Does 12-week qigong training lead to significant enhancement in serum adiponectin, serum BDNF and significant reduction in salivary cortisol? * Does 12-week qigong training bring significant improvement in global cognitive function? Participants are older adults aged 60 or above. They were randomly assigned to qigong training, mindfulness training, physical exercise training, or wait-list which all last for 12 weeks. Their changes before and after the 12-week period in depressive symptoms, neurobiological markers, and cognitive functions are assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06804408
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Qigong
Trials testing the same drug.
- NCT06140355 — HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A F · NA · recruiting
- NCT06406283 — Active Young, Healthy Mind. The YoungFitT Project · NA · recruiting
- NCT05675995 — Qigong for Post Acute Sequelae of COVID-19 Infection · NA · completed
- NCT06877325 — Synergistic Effects of Traditional Chinese Medicine Practices and Pelvic Floor Muscle Training · NA · completed
- NCT04917107 — CREATION: A Clinical Trial of Qigong for Neuropathic Pain Relief in Adults With Spinal Cord Injury · NA · terminated
Other recruiting trials for Qigong
Currently open trials in the same condition.
- NCT07439224 — Qigong and Multicomponent Exercise in Panic Disorder · NA · recruiting
Other The Hong Kong Polytechnic University trials
Trials by the same sponsor.
- NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
- NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
- NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
- NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
- NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06804408 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
- Last refreshed: 3 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06804408.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing